Avanos Medical (AVNS) Competitors

Avanos Medical (NYSE:AVNS) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.

Does the media refer more to AVNS or LMAT?

In the previous week, LeMaitre Vascular had 9 more articles in the media than Avanos Medical. MarketBeat recorded 19 mentions for LeMaitre Vascular and 10 mentions for Avanos Medical. LeMaitre Vascular's average media sentiment score of 0.51 beat Avanos Medical's score of 0.20 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LeMaitre Vascular	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, AVNS or LMAT?

LeMaitre Vascular has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$687.80M	0.82	-$61.80M	-$8.53	-1.44
LeMaitre Vascular	$219.86M	8.09	$30.10M	$1.94	40.57

Is AVNS or LMAT more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to Avanos Medical's net margin of 2.30%. LeMaitre Vascular's return on equity of 13.15% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	2.30%	4.70%	3.46%
LeMaitre Vascular	19.40%	13.15%	11.47%

Which has more volatility & risk, AVNS or LMAT?

Avanos Medical has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.

Do institutionals and insiders hold more shares of AVNS or LMAT?

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 2.6% of Avanos Medical shares are held by company insiders. Comparatively, 10.8% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Do analysts recommend AVNS or LMAT?

LeMaitre Vascular has a consensus target price of $98.14, indicating a potential upside of 24.71%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.63

Does the MarketBeat Community favor AVNS or LMAT?

LeMaitre Vascular received 428 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 55.77% of users gave Avanos Medical an outperform vote.

Company	Underperform	Outperform
Avanos Medical	Outperform Votes 87 55.77%	Underperform Votes 69 44.23%
LeMaitre Vascular	Outperform Votes 515 70.45%	Underperform Votes 216 29.55%

Summary

LeMaitre Vascular beats Avanos Medical on 16 of the 19 factors compared between the two stocks.